What were the key results from the ADORING 1 and ADORING 2 pivotal trials for tapinarof in terms of efficacy?
Featuring Joshua Zeichner, MD |
Director of Cosmetic and Clinical Research
Icahn School of Medicine at Mount Sinai
New York, NY
Related CME
Related Media
Powered by Polaris TM